Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 198

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

CFM RESOLUTION No. 2,463, OF JUNE 25, 2026

Amends CFM Resolution No. 2,386, of August 21, 2024, to expand the transparency duties and conflict-of-interest disclosure requirements applicable to medical entities.

Note: CFM Resolution No. 2,463/2026 expanded the scope of Resolution No. 2,386/2024, which governs the ties between physicians and the pharmaceutical, supplies and medical equipment industries. The rules now apply, as appropriate, to specialty societies, associations, colleges, federations and other medical entities recognized in the country. The participation in the production or dissemination of technical content with repercussions on medical practice was also included among the situations that characterize a tie, with a conflict of interest being considered to be one arising from a relationship maintained in the 12 months prior to the technical or institutional statement. The rule also repealed the provision that excluded from the transparency regime the benefits received by scientific societies and medical entities, subjecting them to disclosure duties when their activities may influence clinical conduct, protocols, guidelines or technical recommendations. The amendment seeks to ensure uniform treatment among physicians, medical legal entities and scientific entities, without presuming irregularity from the existence of sponsorships or other ties. Resolution No. 2,463/2026 enters into force 90 days after its publication, which took place on July 30, 2026.

NOTICE

On this date, the Authorization to Operate is granted to the Health Care Plan Operators listed below, after the Directorate of Standards and Qualification of Operators – DIOPE and the Directorate of Standards and Qualification of Products – DIPRO concluded their analysis of their Authorization to Operate proceedings, under Normative Resolution – RN No. 543, of September 2, 2022, and its subsequent amendments.

Corporate Name

Operator Registration

Case Number

VIVERRIO SAÚDE LTDA.

42500-1

33910.016593/2026-60

ANS news

ANS launches tool for consulting procedure and medication codes

The National Supplementary Health Agency (ANS) has made available a new platform for consulting the tables of the Unified Supplementary Health Terminology (TUSS). The Terminology Management System gathers the codes used by health plan operators and by service providers (health professionals, laboratories, clinics and hospitals) to identify procedures, tests, medications, materials and other items related to the care of beneficiaries. https://www.gov.br/ans/pt-br/assuntos/noticias-1/periodo-eleitoral/ans-lanca-ferramenta-para-consulta-a-codigos-de-procedimentos-e-medicamentos

Open public consultations

CP 174. Subject: submission of comments and suggestions on the preliminary recommendation for incorporation of the technology contained in UAT No. 201 – Bronchoscopy with cryobiopsy. Deadline: Jul 23, 2026 to Aug 11, 2026.

Scheduled public hearings

There are no public hearings scheduled.

Open public calls for input

There is no open public call for input.

Open public calls

Discount cards, prepaid cards, or related services. Deadline: From Jun 2, 2026 to Aug 3, 2026.

Other news

Suspension of content from the Ministry and regulatory agencies harms social participation and transparency, sources warn.

Source: futurodasaude.com.br · read the full article

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.